Ensure adequate protein intake (generally 0.8-1.2 g per kilogram of body weight daily, though this should be individualised, particularly if you have kidney disease)
PubMed Teichman, S.L., Neale, A., Lawrence, B., Gagnon, C., Castaigne, J.P., & Frohman, L.A
India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
Is It Worth Buying as a Supplement
At 3 mg/ml, doses like 0.25 mg convert to 8.3 units, a number that does not land on a clean syringe marking
Yes, as with other incretin-based therapies, nausea, diarrhea, and reduced appetite are among the most commonly reported side effects, especially during dose escalation